4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†

Affiliations

• ¹ European School of Oncology (ESO), European Society for Medical Oncology (ESMO) and Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. Electronic address: [email protected].
• ² European Society for Medical Oncology (ESMO) and Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
• ³ European School of Oncology, Milan, Italy.
• ⁴ Europa Donna Cyprus, Nicosia, Cyprus.
• ⁵ Oncology Department, Clinique de Genolier, Genolier, Switzerland.
• ⁶ Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
• ⁷ Breast Centre, Department of Obstetrics and Gynaecology, University of Munich (LMU), Munich, Germany.
• ⁸ Direction Office, ULACCAM (Union Latinoamericana Contra el Cáncer de la Mujer), Mexico DF, Mexico.
• ⁹ Department of Oncology, PURCS School of Medicine, Porto Alegre, Brazil.
• ¹⁰ Department of Oncology-Pathology, Karolinska Institute & University Hospital, Stockholm, Sweden.
• ¹¹ European Society of Breast Cancer Specialists (EUSOMA) and Department of Medical Oncology, Nuovo Ospedale di Prato - Istituto Toscano Tumori, Prato, Italy.
• ¹² CB Boers Organization, Wormer, The Netherlands.
• ¹³ Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation and Nova Medical School, Lisbon, Portugal.
• ¹⁴ Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, USA.
• ¹⁵ Department of Oncology, Vall d' Hebron University, Barcelona, Spain.
• ¹⁶ Division of Early Drug Development, Department of Oncology and Hemato-Oncology, European Institute of Oncology, University of Milano, Milano, Italy.
• ¹⁷ Gynaecology and Breast Department, Centre Eugène Marquis, Rennes, France.
• ¹⁸ Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon.
• ¹⁹ Breast Cancer Department, Cancer Institute Ion Chiricuta, Cluj-Napoca, Romania.
• ²⁰ SHORE-C, Brighton & Sussex Medical School, University of Sussex, Brighton, UK.
• ²¹ Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
• ²² Medical Oncology Department, BC Cancer Agency, Vancouver, Canada.
• ²³ Department of Medicine, The Royal Marsden, Sutton, UK.
• ²⁴ Department of Oncology, Sheba Medical Center, Ramat Gan, Israel.
• ²⁵ Department of Medical Oncology, Bombay Hospital Institute of Medical Sciences, Mumbai, India.
• ²⁶ Breast Oncology Center Dana-Farber Cancer Institute, Boston, USA.
• ²⁷ Advanced BC.org, New York, USA.
• ²⁸ Advocacy Department, UWOCASO (Uganda Women's Cancer Support Organization), Kampala, Uganda.
• ²⁹ European Society of Radiation Oncology (ESTRO) and Department of Experimental Clinical Oncology & Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
• ³⁰ Cancer Institute Hospital, Breast Oncology Centre, Tokyo, Japan.
• ³¹ Institute of Oncology of Southern Switzerland, Geneva University Hospitals, Swiss Group for Clinical Cancer Research (SAKK), International Breast Cancer Study Group (IBCSG), Bellinzona, Switzerland.
• ³² Oncology Institute, Shaare Zedek Medical Centre, Jerusalem, Israel.
• ³³ Department of Pathology, Centre Jean Perrin, Clermont-Ferrand Cedex, France.
• ³⁴ IDIBAPS (Institut d'Investigacions Biomèdiques August Pi iSunyer), Hospital Clínic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumor, Barcelona, Spain.
• ³⁵ Breast Oncology Clinical Trials Education, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
• ³⁶ Oncology Division, Stanford University Medical Center, Stanford, USA.
• ³⁷ Policy Department, Breast Cancer Network Australia, Camberwell, VIC, Australia.
• ³⁸ Department of Gynaecology, Martin Luther University Halle-Wittenburg, Halle, Germany.
• ³⁹ Oncology Department, Sandton Oncology Centre, Johannesburg, South Africa.
• ⁴⁰ Department of Medical Oncology, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China.
• ⁴¹ Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York.
• ⁴² Dana-Farber Cancer Institute, Susan Smith Center for Women's Cancers, Breast Oncology Center, Boston, USA.